These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16581236)

  • 21. [Pharmacotherapy of bronchial asthma].
    Randerath W; Rühle KH
    Med Monatsschr Pharm; 2001 Apr; 24(4):109-18. PubMed ID: 11338634
    [No Abstract]   [Full Text] [Related]  

  • 22. [New drugs; omalizumab].
    Cohen AF; Dubois EA; van Bronswijk H
    Ned Tijdschr Geneeskd; 2006 Dec; 150(52):2871-2. PubMed ID: 17319219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Animal models of asthma: value, limitations and opportunities for alternative approaches.
    Holmes AM; Solari R; Holgate ST
    Drug Discov Today; 2011 Aug; 16(15-16):659-70. PubMed ID: 21723955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methods used in clinical development of novel anti-asthma therapies.
    Diamant Z; Boot D; Kamerling I; Bjermer L
    Respir Med; 2008 Mar; 102(3):332-8. PubMed ID: 18061420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between inflammation and symptoms in asthma.
    Tillie-Leblond I; Montani D; Crestani B; de Blic J; Humbert M; Tunon-de-Lara M; Magnan A; Roche N; Ostinelli J; Chanez P
    Allergy; 2009 Mar; 64(3):354-67. PubMed ID: 19210358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asthma targets: research dilemma.
    Dove A
    Nat Biotechnol; 1999 Feb; 17(2):128-9. PubMed ID: 10052341
    [No Abstract]   [Full Text] [Related]  

  • 27. Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic.
    Arnett HA; Viney JL
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1084-92. PubMed ID: 17804112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical management of chronic obstructive pulmonary disease and asthma in an obese patient.
    Lessard A; Maltais F; Boulet LP
    Expert Opin Pharmacother; 2008 Jan; 9(1):83-93. PubMed ID: 18076340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Airway smooth muscle as a model for new investigative drugs in asthma.
    Baroffio M; Crimi E; Brusasco V
    Ther Adv Respir Dis; 2008 Jun; 2(3):129-39. PubMed ID: 19124365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic targets for new therapy for corticosteroid refractory asthma.
    Ito K; Mercado N
    Expert Opin Ther Targets; 2009 Sep; 13(9):1053-67. PubMed ID: 19659447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
    Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of asthma control and its impact on optimal treatment strategy.
    Lundback B; Dahl R
    Allergy; 2007 Jun; 62(6):611-9. PubMed ID: 17508964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug therapy of bronchial asthma from the point of view of medicines, based on evidence].
    Chuchalin AG; Tsoĭ AN; Arkhipov VV
    Ter Arkh; 2003; 75(3):73-7. PubMed ID: 12718228
    [No Abstract]   [Full Text] [Related]  

  • 34. Nonadherence to medical therapy in asthma: risk factors, barriers, and strategies for improving.
    Howell G
    J Asthma; 2008 Nov; 45(9):723-9. PubMed ID: 18972285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild persistent asthma: is any treatment needed?
    Lazarus SC
    J Allergy Clin Immunol; 2006 Oct; 118(4):805-8. PubMed ID: 17030230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New perspectives in GINA Asthma Guideline 2006].
    Gillissen A; Wirtz H; Hoheisel G
    Med Klin (Munich); 2007 May; 102(5):399-403. PubMed ID: 17497092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-asthmatic drug prescriptions to an Italian paedriatic population.
    Bianchi M; Clavenna A; Labate L; Bortolotti A; Fortino I; Merlino L; Locatelli GW; Giuliani G; Bonati M
    Pediatr Allergy Immunol; 2009 Sep; 20(6):585-91. PubMed ID: 18771473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical safety and pharmacology of an anti-human interleukin-13 monoclonal antibody in normal macaques and in macaques with allergic asthma.
    Martin PL; Fisher D; Glass W; O'Neil K; Das A; Martin EC; Li L
    Int J Toxicol; 2008; 27(5):351-8. PubMed ID: 19037805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on the pathogenesis and management of childhood asthma.
    Cornell A; Shaker M; Woodmansee DP
    Curr Opin Pediatr; 2008 Oct; 20(5):597-604. PubMed ID: 18781125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.